C145H148F6N26O17S6 — CID 159201090
N-[4-(3-cyano-1-cyclobutyl-6-pyrazol-1-ylindol-2-yl)phenyl]propane-1-sulfonamide;N-[4-[3-cyano-1-(cyclopropylmethyl)-6-pyridin-2-yloxyindol-2-yl]phenyl]propane-1-sulfonamide;N-[4-[3-cyano-1-(cyclopropylmethyl)-6-pyrimidin-2-yloxyindol-2-yl]-3-methylphenyl]propane-1-sulfonamide;1-(cyclopropylmethyl)-2-[4-(propan-2-ylsulfamoylamino)phenyl]-6-(trifluoromethoxy)indole-3-carbonitrile;6-ethoxy-1-ethyl-2-[4-(propan-2-ylsulfamoylamino)phenyl]indole-3-carbonitrile;1-ethyl-2-[4-(propan-2-ylsulfamoylamino)phenyl]-6-(trifluoromethoxy)indole-3-carbonitrile (PubChem CID 159201090) has the molecular formula C145H148F6N26O17S6 and a molecular weight of 2833.33 g/mol. Its IUPAC name is N-[4-(3-cyano-1-cyclobutyl-6-pyrazol-1-ylindol-2-yl)phenyl]propane-1-sulfonamide;N-[4-[3-cyano-1-(cyclopropylmethyl)-6-pyridin-2-yloxyindol-2-yl]phenyl]propane-1-sulfonamide;N-[4-[3-cyano-1-(cyclopropylmethyl)-6-pyrimidin-2-yloxyindol-2-yl]-3-methylphenyl]propane-1-sulfonamide;1-(cyclopropylmethyl)-2-[4-(propan-2-ylsulfamoylamino)phenyl]-6-(trifluoromethoxy)indole-3-carbonitrile;6-ethoxy-1-ethyl-2-[4-(propan-2-ylsulfamoylamino)phenyl]indole-3-carbonitrile;1-ethyl-2-[4-(propan-2-ylsulfamoylamino)phenyl]-6-(trifluoromethoxy)indole-3-carbonitrile.
| Compound Name | N-[4-(3-cyano-1-cyclobutyl-6-pyrazol-1-ylindol-2-yl)phenyl]propane-1-sulfonamide;N-[4-[3-cyano-1-(cyclopropylmethyl)-6-pyridin-2-yloxyindol-2-yl]phenyl]propane-1-sulfonamide;N-[4-[3-cyano-1-(cyclopropylmethyl)-6-pyrimidin-2-yloxyindol-2-yl]-3-methylphenyl]propane-1-sulfonamide;1-(cyclopropylmethyl)-2-[4-(propan-2-ylsulfamoylamino)phenyl]-6-(trifluoromethoxy)indole-3-carbonitrile;6-ethoxy-1-ethyl-2-[4-(propan-2-ylsulfamoylamino)phenyl]indole-3-carbonitrile;1-ethyl-2-[4-(propan-2-ylsulfamoylamino)phenyl]-6-(trifluoromethoxy)indole-3-carbonitrile |
|---|---|
| PubChem CID | 159201090 |
| Molecular Formula | C145H148F6N26O17S6 |
| Molecular Weight | 2833.33 g/mol |
| Exact Mass | 2830.97 |
| IUPAC Name | N-[4-(3-cyano-1-cyclobutyl-6-pyrazol-1-ylindol-2-yl)phenyl]propane-1-sulfonamide;N-[4-[3-cyano-1-(cyclopropylmethyl)-6-pyridin-2-yloxyindol-2-yl]phenyl]propane-1-sulfonamide;N-[4-[3-cyano-1-(cyclopropylmethyl)-6-pyrimidin-2-yloxyindol-2-yl]-3-methylphenyl]propane-1-sulfonamide;1-(cyclopropylmethyl)-2-[4-(propan-2-ylsulfamoylamino)phenyl]-6-(trifluoromethoxy)indole-3-carbonitrile;6-ethoxy-1-ethyl-2-[4-(propan-2-ylsulfamoylamino)phenyl]indole-3-carbonitrile;1-ethyl-2-[4-(propan-2-ylsulfamoylamino)phenyl]-6-(trifluoromethoxy)indole-3-carbonitrile |
| SMILES | CC(C)NS(=O)(=O)Nc1ccc(-c2c(C#N)c3ccc(OC(F)(F)F)cc3n2CC2CC2)cc1.CCCS(=O)(=O)Nc1ccc(-c2c(C#N)c3ccc(-n4cccn4)cc3n2C2CCC2)cc1.CCCS(=O)(=O)Nc1ccc(-c2c(C#N)c3ccc(Oc4ccccn4)cc3n2CC2CC2)cc1.CCCS(=O)(=O)Nc1ccc(-c2c(C#N)c3ccc(Oc4ncccn4)cc3n2CC2CC2)c(C)c1.CCOc1ccc2c(C#N)c(-c3ccc(NS(=O)(=O)NC(C)C)cc3)n(CC)c2c1.CCn1c(-c2ccc(NS(=O)(=O)NC(C)C)cc2)c(C#N)c2ccc(OC(F)(F)F)cc21 |
| InChI | InChI=1S/C27H27N5O3S.C27H26N4O3S.C25H25N5O2S.C23H23F3N4O3S.C22H26N4O3S.C21H21F3N4O3S/c1-3-13-36(33,34)31-20-7-9-22(18(2)14-20)26-24(16-28)23-10-8-21(35-27-29-11-4-12-30-27)15-25(23)32(26)17-19-5-6-19;1-2-15-35(32,33)30-21-10-8-20(9-11-21)27-24(17-28)23-13-12-22(34-26-5-3-4-14-29-26)16-25(23)31(27)18-19-6-7-19;1-2-15-33(31,32)28-19-9-7-18(8-10-19)25-23(17-26)22-12-11-21(29-14-4-13-27-29)16-24(22)30(25)20-5-3-6-20;1-14(2)28-34(31,32)29-17-7-5-16(6-8-17)22-20(12-27)19-10-9-18(33-23(24,25)26)11-21(19)30(22)13-15-3-4-15;1-5-26-21-13-18(29-6-2)11-12-19(21)20(14-23)22(26)16-7-9-17(10-8-16)25-30(27,28)24-15(3)4;1-4-28-19-11-16(31-21(22,23)24)9-10-17(19)18(12-25)20(28)14-5-7-15(8-6-14)27-32(29,30)26-13(2)3/h4,7-12,14-15,19,31H,3,5-6,13,17H2,1-2H3;3-5,8-14,16,19,30H,2,6-7,15,18H2,1H3;4,7-14,16,20,28H,2-3,5-6,15H2,1H3;5-11,14-15,28-29H,3-4,13H2,1-2H3;7-13,15,24-25H,5-6H2,1-4H3;5-11,13,26-27H,4H2,1-3H3 |
| InChIKey | KPHMXQUUYHGWHY-UHFFFAOYSA-N |
| XLogP | 30.95 |
| TPSA | 588.07 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 48 |
| Heavy Atoms | 200 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2833.33 |
| LogP ≤ 5 | 30.95 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 34 |